Product Wiki · Recalls · Health Canada — Medical Devices

Azurion and Allura Systems — recall 76771

Health Canada — Medical Devices · Canada · 2024-12-30 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
76771
Date of alert
2024-12-30
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Radiology
Product type
Medical devices
Reported risk: Philips has identified that due to the forces applied during the movement of the c-arc of the Azurion and Allura systems, the bolts supporting the FlexMove carriage may become loose and/or break, and cracks may appear in the FlexMove carriage. If FlexMove rail fixation bolts become loose or broken, or cracks appear in the carriage, the following issues may occur: • transversal movements of the c-arc stop due to false collision detections because of additional friction. • manual movement of the FlexMove carriage not possible due to added friction. • abnormal noise during transversal movement of the c-arc. • unstable c-arc suspension. • fall of the c-arc assembly (1,500 kg), if all bolts in the x-axis would break/get loose. • drop of the c-arc assembly (up to 10cm if c- arc is at one side of the rail, up to 5 cm if c-arc is in the center of the rails, and 1.5 cm if the c-arc is in the anterior/posterior position), if all bolts in the y-axis would break/get loose. Recall start date: December 12, 2024
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/azurion-and-allura-systems

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.